Stay updated on MiST: Multi-drug Phase II Clinical Trial
Sign up to get notified when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.

Latest updates to the MiST: Multi-drug Phase II Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study content with a generic error screen and site header/footer. This indicates restricted access to the page rather than changes to the study record text.SummaryDifference21%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This appears to be a minor deployment update rather than a substantive change to study details or page content.SummaryDifference0.1%

- Check49 days agoChange DetectedMiST study page now shows the trial is completed and no longer recruiting, with results posted (including 12- and 24-week disease control rate and objective response rate). It also adds several study documents and protocol PDFs to the page.SummaryDifference4%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small update to the study record on ClinicalTrials.gov. This change does not alter core study content or user-facing information.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page template or content.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance or small improvement to the site. This change does not affect the study information or user-facing data.SummaryDifference0.1%

Stay in the know with updates to MiST: Multi-drug Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.